Tetraspaniny i ich rola w przebiegu zakażeń wirusowych

• Autorzy: Szulc L. , Boratynska A. , Niemialtowski M.

Warianty tytułu

EN

Tetraspanins and their role in viral infections

• Języki publikacji: PL

Abstrakty

EN

Tetraspanins are a superfamily of surface membrane proteins characterized by their four transmembrane domains. They associate laterally with their partner proteins or with each other, and form large integrated signaling complexes or tetraspanin enriched microdomains (TEMs). Consequently, those proteins are involved in the coordination of many biological processes, including cell adhesion, migration and proliferation. Tetraspanins also play a prominent role in the pathogenesis of viral infectious diseases. Viruses can exploit tetraspanins for the modulation of the host immune response and/or for subsequent immune evasion. Thus tetraspanins are attractive novel antiviral therapeutic targets, which may provides a novel strategy to inhibit critical processes of viral infection. This review summarizes the involvement of tetraspanins in viral life cycles, including adsorption, entry, viral trafficking, fusion events and viral release.

Słowa kluczowe

PL

choroby wirusowe; infekcja wirusowa; tetraspaniny; budowa; funkcje

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 06
• Opis fizyczny: s.385-389,rys.,bibliogr.

Twórcy

autor

Szulc L.

• Zakład Immunologii, Katedra Nauk Przedklinicznych, Wydział Medycyny Weterynaryjnej, Szkoła Główna Gospodarstwa Wiejskiego, ul.Ciszewskiego 8, 02-786 Warszawa

autor

Boratynska A.

autor

Niemialtowski M.

Bibliografia

• 1. Charrin S., Manié S., Thiele C., Billard M., Gerlier D., Boucheix C., Rubinstein E.: A physical and functional link between cholesterol and tetraspanins. Eur. J. Immunol. 2003, 33, 2479-2489.
• 2. Chen H., Dziuba N., Friedrich B., von Lindern J., Murray J. L., Rojo D. R., Hodge T. W., O'Brien W. A., Ferguson M. R.: A critical role for CD63 in HIV replication and infection of macrophages and cell lines. Virology 2008, 379, 191-196.
• 3. Cherukuri A., Carter R. H., Brooks S., Bornmann W., Finn R., Dowd C. S., Pierce S. K.: B cell signaling is regulated by induced palmitoylation of CD81. J. Biol. Chem. 2004, 279, 31973-31982.
• 4. Clercq E. De: Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30, 115-133.
• 5. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., Mosca M., Filliponi F., Brunetto R. M., Bonino F., Abrignani S., Valiante N. M.: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 2002, 195, 35-41.
• 6. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M.: In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell. Biol. 2007, 177, 329-341.
• 7. Deng J., Dekruyff R. H., Freeman G. J., Umetsu D. T., Levy S.: Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int. Immunol. 2002, 14, 513-523.
• 8. Flint M., Maidens C., Loomis-Price L. D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., McKeating J. A.: Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 1999, 73, 6235-6244.
• 9. Fukudome K., Furuse M., Imai T., Nishimura M., Takagi S., Hinuma Y., Yoshie O.: Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 1992, 66, 1394-1401.
• 10. Funakoshi T., Tachibana I., Hoshida Y., Kimura H., Takeda Y., Kijima T., Nishino K., Goto H., Yoneda T., Kumagai T., Osaki T., Hayashi S., Aozasa K., Kawase I.: Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene 2003, 22, 674-687.
• 11. Harris H. J., Davis C., Mullins J. G. L., Hu K., Goodall M., Farquhar M. J., Mee C. J., McCaffrey K., Young S., Drummer H., Balfe P., McKeating J. A.: Claudin association with CD81 defines hepatitis C virus entry. J. Biol. Chem. 2010, 285, 21092-21102.
• 12. Hart A. M., Wilson A. D. H., Montovani C., Smith C., Johnson M., Terenghi G., Youle M.: Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 2004, 18, 1549-1560.
• 13. Hasegawa H., Nomura T., Kishimoto K., Yanagisawa K., Fujita S.: SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with α₅β₁ integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin. J. Immunol. 1998, 161, 3087-3095.
• 14. Jolly C., Sattentau Q. J.: Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 2007, 81, 7873-7884.
• 15. Kropshofer H., Spindeldreher S., Röhn T. A., Platania N., Grygar C., Daniel N., Wölpl A., Langen H., Horejsi V., Vogt A. B.: Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 2001, 3, 61-68.
• 16. Levy S., Shoham T.: Protein-protein interactions in the tetraspanin web. Physiology 2005, 20, 218-224.
• 17. Levy S., Shoham T.: The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 2005, 5, 136-148.
• 18. Lindern J. J. von, Rojo D., Grovit-Ferbas K., Yeramian C., Deng C., Herbein G., Ferguson M. R., Pappas T. C., Decker J. M., Singh A., Collman R. G., O'Brien W. A.: Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol. 2003, 77, 3624-3633.
• 19. Löffler S., Lottspeich F., Lanza F., Azorsa D. O., ter Meulen V., Schneider-Schaulies J.: CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol. 1997, 71, 42-49.
• 20. Maecker H. T., Do M. S., Levy S.: CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. USA 1998, 95, 2458-2462.
• 21. Martin F., Roth D. M., Jans D. A., Pouton C. W., Partridge L. J., Monk P. N., Moseley G. W.: Tetraspanins in viral infections: a fundamental role in viral biology? J. Virol. 2005, 79, 10839-10851.
• 22. Masciopinto F., Giovani C., Campagnoli S., Galli-Stampino L., Colombatto P., Brunetto M., Yen T. S. B., Houghton M., Pileri P., Abrignani S.: Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 2004, 34, 2834-2842.
• 23. Meerloo T., Parmentier H. K., Osterhaus A. D., Goudsmit J., Schuurman H. J.: Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 1992, 6, 1105-1116.
• 24. Mittelbrunn M., Yáńez-Mó M., Sancho D., Ursa Á., Sánchez-Madrid F.: Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 2002, 169, 6691-6695.
• 25. Nakajima H., Cocquerel L., Kiyokawa N., Fujimoto J., Levy S.: Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Biochem. Biophys. Res. Commun. 2005, 328, 1091-1100.
• 26. Naour F. Le, André M., Greco C., Billard M., Sordat B., Emile J.-F., Lanza F., Boucheix C., Rubinstein E.: Profiling of the tetraspanin web of human colon cancer cells. Mol. Cell. Proteomics 2006, 5, 845-857.
• 27. Nattermann J., Nischalke H. D., Kupfer B., Rockstroh J., Hess L., Sauerbruch T., Spengler U.: Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003, 17, 1457-1462.
• 28. Nitkiewicz J.: Przewlekłe zakażenie wirusem zapalenia wątroby typu C - mechanizmy "ucieczki immunologicznej" wirusa. Przegl. Epidemiol. 2004, 58, 423-433.
• 29. Nydegger S., Khurana S., Krementsov D. N., Foti M., Thali M.: Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J. Cell. Biol. 2006, 173, 795-807.
• 30. Parseval A. de, Lerner D. L., Borrow P., Willett B. J., Elder J. H.: Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J. Virol. 1997, 71, 5742-5749.
• 31. Rocha-Perugini V., Montpellier C., Delgrange D., Wychowski C., Helle F., Pillez A., Drobecq H., Le Naour F., Charrin S., Levy S., Rubinstein E., Dubuisson J., Cocquerel L.: The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS ONE 2008, 3, e1866.
• 32. Sasaki M., Yamauchi K., Nakanishi T., Kamogawa Y., Hayashi N.: In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines. J. Gastroenterol. Hepatol. 2003, 18, 74-79.
• 33. Shanmukhappa K., Kim J.-K., Kapil S.: Role of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection. Virol. J. 2007, 4, 62.
• 34. Singethan K., Topfstedt E., Schubert S., Duprex W. P., Rima B. K., Schneider-Schaulies J.: CD9-dependent regulation of Canine distemper virus-induced cell-cell fusion segregates with the extracellular domain of the haemagglutinin. J. Gen. Virol. 2006, 87, 1635-1642.
• 35. Spriel A. B. van, Figdor C. G.: The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect. 2010, 12, 106-112.
• 36. VanCompernolle S. E., Levy S., Todd S. C.: Anti-CD81 activates LFA-1 on T cells and promotes T cell-B cell collaboration. Eur. J. Immunol. 2001, 31, 823-831.
• 37. Willett B. J., Hosie M. J., Jarrett O., Neil J. C.: Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 1994, 81, 228-233.
• 38. Zemni R., Bienvenu T., Vinet M. C., Sefiani A., Carrié A., Billuart P., McDonell N., Couvert P., Francis F., Chafey P., Fauchereau F., Friocourt G., des Portes V., Cardona A., Frints S., Meindl A., Brandau O., Ronce N., Moraine C., van Bokhoven H., Ropers H. H., Sudbrak R., Kahn A., Fryns J. P., Beldjord C., Chelly J.: A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet. 2000, 24, 167-170.